Core One Labs’ (COOL.C) wholly-owned subsidiary Akome Biotech announced they are initiating the next step of their clinical development of their patent-pending psychedelic formulations AKO001 and AKO003. The next…
Core One
Core One Labs (COOL.C) announced they have reached a definitive share purchase agreement which will see it acquire all outstanding share capital of Akome Biotech. Akome Biotech’s goal is…
Core One Labs (COOL.C) announced they have acquired the Ketamine Infusion Centers of Texas (KITC), a health and wellness clinic that provides ketamine infusion therapy. The acquisition provides…